Affordable Insulin for the COVID–19 Emergency Act
Latest action · May 28, 2020 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 28, 2020
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Affordable Insulin for the COVID-19 Emergency Act
This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
Cosponsors 43
Members who signed on, in the order they did. Signatures ran from May 28, 2020 to Jul 20, 2020; 25 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-FL | Alcee L. Hastings | Original | May 28, 2020 |
| D-IN | André Carson | Original | May 28, 2020 |
| D-CA | Barbara Lee | Original | May 28, 2020 |
| D-MS | Bennie G. Thompson | Original | May 28, 2020 |
| D-IL | Bobby L. Rush | Original | May 28, 2020 |
| D-IL | Daniel Lipinski | Original | May 28, 2020 |
| D-NJ | Donald M. Payne, Jr. | Original | May 28, 2020 |
| D-TX | Eddie Bernice Johnson | Original | May 28, 2020 |
| D-DC | Eleanor Holmes Norton | Original | May 28, 2020 |
| D-FL | Frederica S. Wilson | Original | May 28, 2020 |
| D-NY | Gregory W. Meeks | Original | May 28, 2020 |
| D-CT | Jahana Hayes | Original | May 28, 2020 |
| D-IL | Jesús G. "Chuy" García | Original | May 28, 2020 |
| D-CT | John B. Larson | Original | May 28, 2020 |
| D-NY | Joseph D. Morelle | Original | May 28, 2020 |
| D-OH | Joyce Beatty | Original | May 28, 2020 |
| D-CA | Lucille Roybal-Allard | Original | May 28, 2020 |
| D-CA | Nanette Diaz Barragán | Original | May 28, 2020 |
| D-VT | Peter Welch | Original | May 28, 2020 |
| D-GA | Sanford D. Bishop, Jr. | Original | May 28, 2020 |
| D-TX | Sheila Jackson Lee | Original | May 28, 2020 |
| D-TN | Steve Cohen | Original | May 28, 2020 |
| D-PA | Susan Wild | Original | May 28, 2020 |
| D-TX | Sylvia R. Garcia | Original | May 28, 2020 |
| D-NY | Thomas R. Suozzi | Original | May 28, 2020 |
| D-GA | David Scott | Jun 1, 2020 | |
| D-FL | Darren Soto | Jun 15, 2020 | |
| D-CA | Grace F. Napolitano | Jun 15, 2020 | |
| D-OH | Marcia L. Fudge | Jun 15, 2020 | |
| D-AZ | Raúl M. Grijalva | Jun 15, 2020 | |
| D-NY | Grace Meng | Jun 24, 2020 | |
| D-CO | Joe Neguse | Jun 24, 2020 | |
| D-NY | Jose E. Serrano | Jun 24, 2020 | |
| D-CA | Judy Chu | Jun 24, 2020 | |
| D-OR | Peter A. DeFazio | Jun 24, 2020 | |
| D-MI | Rashida Tlaib | Jun 24, 2020 | |
| D-MD | Anthony G. Brown | Jul 1, 2020 | |
| D-MI | Daniel T. Kildee | Jul 13, 2020 | |
| D-CA | Karen Bass | Jul 13, 2020 | |
| D-PA | Mary Gay Scanlon | Jul 13, 2020 | |
| D-IL | Lauren Underwood | Jul 20, 2020 | |
| D-WI | Mark Pocan | Jul 20, 2020 | |
| D-NY | Nydia M. Velázquez | Jul 20, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 28, 2020 |
| House | Ways and Means Committee | Referred May 28, 2020 |
Actions 2
Everything that happened, newest first.
- May 28, 2020Introduced in House
- May 28, 2020Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 100, May 28, 2020, page H2359.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2179 | Affordable Insulin for the COVID–19 Emergency Act | Reintroduced Bill | Mar 24, 2021 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to eliminate cost-sharing with respect to coverage of insulin as a covered part D drug and associated medical supplies and to provide mail order access to insulin and such supplies under the Medicare program during the COVID-19 emergency period.
- Short Title(s) as Introduced
- Affordable Insulin for the COVID–19 Emergency Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 28, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.